Abstract Search

ea0101op-12-04 | Oral Session 12: Clinical thyroid cancer research | ETA2024

Pronosthyc: prognostic factors in radioiodine refractory differentiated thyroid cancer with distant metastases, a multicentric study from a french network of referral centers

Sagnella Alfonso , Lasolle Helene , Godbert Yann , Do Cao Christine , Drui Delphine , Hescot Segolene , Laramas Mathieu , Sage Clemence , Wassermann Johanna , Roudaut Nathalie , Illouz Frederic , Borson-Chazot Francoise , Bachir Abdelouahab Macine , Hadoux Julien , Borget Isabelle , Buffet Camille , Lamartina Livia

Background: Radioiodine-refractory differentiated thyroid cancer (RAI-R DTC) patients with distant metastases show poor survival rates. However, patients outcome can be very heterogeneous, with cases spanning from microscopic slowly growing metastases to symptomatic, rapidly progressive disease. The aim of this study was to assess the overall survival (OS) of RAI-R DTC patients with distant metastases and to identify the prognostic factors associated with OS.<p class...

0 shares

Endocrine Abstracts

Pronosthyc: prognostic factors in radioiodine refractory differentiated thyroid cancer with distant metastases, a multicentric study from a french network of referral centers

BiosciAbstracts